New Zealand markets open in 5 hours 32 minutes

BIIB Jan 2024 110.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
3.90000.0000 (0.00%)
As of 03:16PM EDT. Market open.
Full screen
Previous close3.9000
Open3.8000
Bid0.4000
Ask4.6000
Strike110.00
Expiry date2024-01-19
Day's range3.8000 - 3.9000
Contract rangeN/A
Volume14
Open interest23
  • GlobeNewswire

    Biogen Provides Update on FDA Advisory Committee Meeting on Tofersen for SOD1-ALS

    SOD1-ALS is a rare genetic form of the disease affecting approximately 330 people in the United StatesCAMBRIDGE, Mass., March 22, 2023 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) announced today the outcome of the U.S. Food and Drug Administration’s (FDA) Peripheral and Central Nervous System Drugs Advisory Committee meeting on tofersen, an investigational product for the treatment of superoxide dismutase 1 (SOD1) amyotrophic lateral sclerosis (ALS). On the question, “Is the available evidenc

  • Zacks

    Biogen Inc. (BIIB) Stock Sinks As Market Gains: What You Should Know

    Biogen Inc. (BIIB) closed the most recent trading day at $266.15, moving -0.66% from the previous trading session.

  • Motley Fool

    Should You Buy Biogen Before a Big July Decision?

    Over time, Biogen (NASDAQ: BIIB) created a true success story. Competition for Biogen's MS blockbuster Tecfidera, and for other key products, entered the market. Now, though, Biogen may have found that new growth source.